Update on health-related quality of life in patients with gastroesophageal reflux disease

References

• Robinson M. Dyspepsia: challenges in diagnosis and selection of treatment. Clin. Ther. 23, 1130–1144 (2001).
   PubMedGoogle Scholar
• Szarka LA, DeVault KR, Murray JA. Diagnosing gastroesophageal reflux disease. A/4o Clin. Proc. 76, 97–101 (2001).
   Google Scholar
• Richter JE, Peura D, Benjamin SB, Joelsson B, Whipple J. Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis. Arch. Intern Merl 160, 1810–1816 (2000).
   Google Scholar
• Avidan B, Sonnenberg A, Schnell 1U, Sontag SJ. Hiatal hernia and acid reflux frequency predict presence and length of Barrett's esophagus. Thg. Dis. Sci. 47, 256–264 (2002).
   Google Scholar
• Shaheen N, Ransohoff DE Gastroesophageal reflux, Barrett esophagus and esophageal cancer: scientific review. JA/V/4 287, 1972–1981 (2002).
   Google Scholar
• Richter JE. Peptic strictures of the esophagus. Gastroenteml Gun. North Am. 28, 875–891 (1999).
   PubMedGoogle Scholar
• Valipour A, Makker HK, Hardy R, Emegbo S, Toma T, Spiro SG. Symptomatic gastroesophageal reflux in subjects with a breathing sleep disorder. Chest 121, 1748–1753 (2002).
   PubMed Web of Science ®Google Scholar
• Shrestha S, Pasricha PJ. Update on noncardiac chest pain. Dig. Dis. 18, 138–146 (2000).
   PubMedGoogle Scholar
• Alexander JA, Hunt LW Patel AM. Prevalence, pathophysiology and treatment of patients with asthma and gastroesophageal reflux disease. Mayo Gun. Proc. 75, 1055–1063 (2000).
   PubMedGoogle Scholar
• D'Urzo A, Jugovic P Chronic cough. Three most common causes. Can. Fain. Phys. 48, 1311–1316 (2002).
   Google Scholar
• Shaw GY, Searl JP, Young JL, Miner PB. Subjective, laryngoscopic and acoustic measurements of laryngeal reflux before and after treatment with omeprazole. Voice 10, 410–418 (1996).
   Google Scholar
• Rai A, Orlando R. Gastroesophageal reflux disease. CUI7: Opin. Gastroenterol 14, 326–333 (1998).
   Google Scholar
• Thomson AB, Chiba N, Armstrong D, Tougas G, Hunt RII. The secondCanadian gastroesophageal reflux disease consensus: moving forward to new concepts. Can. j Gastroenterol 12, 551–556 (1998).
   Google Scholar
• •Expands the gastroesophageal reflux disease concept.
   Google Scholar
• Thomson ABR, Armstrong D, Barkun AN etal The high prevalence of clinically significant findings (CSFs) at endoscopy (EDG) in patients with uninvestigated dyspepsia (UD) is not predicted by patients' dyspepsia symptoms (CADET-PE Study). Can. .1. Gastroenterol. 16 (Suppl. A), A149 (2002).
   Google Scholar
• Wiklund I. Quality of life in patients with gastroesophageal reflux disease. Am. Gastroenteml. 96 (Suppl.), S46—S53 (2001).
   Google Scholar
• ••Demonstrates that the adverse impact onhealth-related quality of life is equally affected in patients with endoscopy-negative reflux disease and erosive esophagitis.
   Google Scholar
• Frank L, Kleinman L, Ganoczy D etal. Upper gastrointestinal symptoms in North America. Prevalence and relationship to healthcare utilization and quality of life. Dis. Sc]. 45, 809–818 (2000).
   Google Scholar
• Marsland DW, Wood M, Mayo E Content of family practice. Part I. Rank order of diagnoses by frequency. Part II. Diagnoses by disease category and age/sex distribution. j Fain. Pract. 3, 37–68 (1976).
   Google Scholar
• Morell DC, Gage HG, Robinson NA Symptoms in general practice. I Royal Coll. Gen. Pract. 21, 32–43 (1971).
   PubMedGoogle Scholar
• Penston JG, Pounder RE. A survey of dyspepsia in Great Britain. Aliment. Pharmacol Ther. 10, 83–89 (1996).
   PubMed Web of Science ®Google Scholar
• Crawley J, Hamelin B, Gallagher E. Does it matter why heartburn sufferers seek health care? Gastroenterology118, A209 (2000).
   Google Scholar
• Lydeard S, Jones R. Factors affecting the decision to consult with dyspepsia: comparison of consulters and nonconsulters. I Royal Coll Gen Pract. 39, 495–498 (1989).
   PubMedGoogle Scholar
• Drossman DA, Li Z, Andruzzi E etal US householder survey of functional gastrointestinal disorders. Prevalence, sociodemography and health impact. Dig. Dis. Sc]. 38, 1569–1580 (1993).
   PubMed Web of Science ®Google Scholar
• Borgaonkar MR, Irvine EJ. Quality of life measurement in gastrointestinal and liver disorders. Gut 47,444–454 (2000).
   PubMed Web of Science ®Google Scholar
• Revicki DA, Wood M, Maton PN, Sorensen S. The impact of gastroesophageal reflux disease on health-related quality of life. Arm Med 104,252–258 (1998).
   Google Scholar
• Leidy NK, Revicki DA, Geneste B. Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health 2,113–127 (1999).
   Google Scholar
• Ware JE Jr, Sherbourne CD. The MOS 36- Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med. Carr 30,473–483 (1992).
   Google Scholar
• Moyer CA, Fendrick AM. Measuring health related quality of life in patients with upper gastrointestinal symptoms. Dig. Dis. Sc]. 16,315–324 (1998).
   Google Scholar
• Rentz AM, Battista C, Trudeau E eta]. Symptom and health-related quality-of-life measures for use in selected gastrointestinal disease studies. A review and synthesis of the literature. PhatmacoEconomics 19,349–363 (2001).
   Google Scholar
• ••Provides a recent update on availablehealth-related quality of life questionnaires.
   Google Scholar
• Talley NJ, Fullerton S, Junghard 0, Wiklund I. Quality of life in patients with endoscopically-negative heartburn: reliability and sensitivity of disease-specific instruments. Am. j Gastroenteml 96, 1998-2004 (2001).
   Google Scholar
• Stewart AL, Hays RD, Ware JE Jr. The MOS Short-Form General Health Survey. Reliability and validity in a patient population. Med. Carr 26,724–735 (1988).
   Google Scholar
• Wiklund I, Glise H. Quality of life in different gastrointestinal conditions. Eur. Surg. 164 (Suppl. 582), 56–61 (1998).
   Google Scholar
• Talley NJ. Scope of the problem of functional digestive disorders. Eur j Surg. 164 (Suppl. 582), 35–41 (1998).
   Google Scholar
• Wiklund IK, Junghard 0, Grace E et a/. Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (Q0LRAD). Eur Surg Suppl 583,41–49 (1998).
   Google Scholar
• Revicki DA, Sorensen S, Maton PN, Orlando RC. Health related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease. Dig. Dis. 16,284–291 (1998).
   PubMedGoogle Scholar
• Revicki DA, Crawley JA, Zodet MW, Levine DS, Joelsson BO. Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease. Aliment. Pharmacol Ther. 13,1621–30 (1999).
   Google Scholar
• Kaplan-Machlis B, Spiegler GE, Revicki DA. Health-related quality of life in primary care patients with gastroesophageal reflux disease. Ann. Phalmacother. 33, 1032–1036 (1999).
   Google Scholar
• Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health related quality of life. Gastroenterology119,654–660 (2000).
   Google Scholar
• Mant JWP, Jenkinson C, Murphy ME eta]. Use of the Short Form 36 to detect the influence of upper gastrointestinal disease on self-reported health status. Qual Life Res. 7,221-226 (1998).
   Google Scholar
• •Gives a perspective on the impact on health-related quality of life across different chronic diseases.
   Google Scholar
• Farup C, Kleinman L, Sloan S eta]. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch. Intern. Med. 161,45–52 (2001).
   Google Scholar
• Hallerback B, Glise H, Johansson B eta]. Gastro-oesophageal reflux symptoms clinical finding and effect of ranitidine treatment. Eur.j Surg. 583,6–13 (1998).
   Google Scholar
• European Commission — Statistical Office: Eurostat Yearbook 2002 People in Eumpe.' (2002).
   Google Scholar
• Glise H, Wiklund I, Hallerback B. Burden of illness in functional gastrointestinal disorder — the consequences for the individual and society. Eur. j Surg. 164 (Suppl. 583), 67–72 (1998).
   Google Scholar
• Henke CJ, Levin TR, Henning JM, Potter LP Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Arm Gastroenterol 95,788–792 (2000).
   Google Scholar
• ••Highlights the cost of reflux disease.
   Google Scholar
• Wahlqvist P, Carlsson J, Sfalhammar N- O, Wiklund I. Validity of a work productivity and activity impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (wpai-gerd) - results from a cross-sectional study. Value Health 5, 106–113 (2002).
   Google Scholar
• Colwell HH, Mathias SD, Pasta DJ, Henning JM, Hunt RII. Development of ahealth related quality of life questionnaire for individuals with gastroesophageal reflux disease. A validation study. Dig. Dis. Sci. 44,1376–1383 (1999).
   Google Scholar
• Burton WN, Conti DJ, Chen CY, Schultz AB, Edington DW. The role of health risk factors and disease on worker productivity. Occupat. Environ. Med. 41,863–877 (1999).
   Google Scholar
• Acid-related gastrointestinal diseases. The burden of gastrointestinal diseases. American Gastroenterological Association, Bethesda, MD USA, 18–23 (2001).
   Google Scholar
• ••Highlights the cost of reflux disease.
   Google Scholar
• Hamblin M. The Burning question survey. AstraZeneca Press Release (2002).
   Google Scholar
• Sjöland H, Wildund I, Caidahl K, Haglid M, Westberg S, Herlitz J. Improvement in quality of life and exercise capacity after coronary bypass surgery. Arch. Intern Med. 156,265–271 (1996).
   Google Scholar
• Trus TL, Laycock WS, Waring JP, Branum GD, Hunter JG. Improvement in quality of life measures after laparoscopic antireflux surgery. Ann. Surg. 229,331–336 (1999).
   Google Scholar
• Dimenas E, Carlsson G, Glise H et al Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand. Gastroenterol 31 (Suppl. 221), 8–13 (1996).
   Google Scholar
• McDougall NI, Johnston BT, Kee F eta]. Natural history of reflux esophagitis: a ten year follow-up of its effect on patient symptomatology and quality of life. Gut 38, 481–486 (1996).
   PubMed Web of Science ®Google Scholar
• Ware JE, Snow KK, Kosinski M etal SF- 36 Health Survey Manual and Interpretation Guide. The Health Institute, New England Medical Center, Boston, MA, USA (1993).
   Google Scholar
• McCarthy DM. Quality of life: a critical assessment. Land. j Gastroenterol 30, 141–146 (1995).
   Google Scholar
• Glise H. Quality of life assessments in patients with peptic ulcer during treatment and follow-up. Scand j Gastroenterol 28 (Suppl. 199), 34–35 (1993).
   Google Scholar
• Talley NJ, Junghard 0, Wiklund IK. Why do patients with gastroesophageal reflux disease (GERD) have a poor health-related quality of life (HRQ0L)? Gastroenterology 120 (Suppl. A), 423 (2001).
   Google Scholar
• Gallup Organization. Understanding Heartburn in America. The Gallup Organization, Princeton, NJ, USA (2001).
   Google Scholar
• ••Recognizes the underestimation ofnocturnal heartburn and its impact on patients' lives.
   Google Scholar
• Caste11 DO, Kahrilas PJ, Richter JE etal Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am j Gastroenteml 97, 575–583 (2002).
   PubMedGoogle Scholar
• Valipour A, Makker HK, Hardy R etal Symptomatic gastroesophageal reflux in subjects with a breathing sleep disorder. Chest 121, 1748–1753 (2002).
   PubMed Web of Science ®Google Scholar
• Young TL, Kirchdoerfer LJ, Osterhaus JT. A development and validation process for a disease specific quality of life instrument. Drug Info. 30, 185–193 (1996).
   Google Scholar
• Marquis P, Sapede C, Bechade D eta]. Development and psychometric validation of a disease-specific quality of life questionnaire in gastro-oesophageal reflux disease. Qual Life Res. 4, 457–458 (1995).
   Google Scholar
• Pisegna JR. GERD and its complications. The pathogenic relationship between symptoms and disease progression. Postgrad Med. Oct. Spec. 19–23 (2001).
   Google Scholar
• Pass R, Ofman JJ. Gastroesophageal reflux disease — should we adopt a new conceptual framework? Am. .1. Gastroenterol 97, 1901-1909 (2002).
   Google Scholar
• •Points to potential complications.
   Google Scholar
• Wildund I, Bardhan KD, Muller-Lissner S et al for the European Study Group. Quality of life during acute and intermittent treatment of gastroesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicenter clinical trial. Ital. j Gastmenterol Hepatol 30, 19–27 (1998).
   Google Scholar
• Havelund T, Lind T, Wiklund I et al. Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. A117. I Gastroenterol. 94, 1782–1789 (1999).
   Google Scholar
• Allen CJ, Parameswaran K, Belda J et al. Reproducibility, validity and responsiveness of a disease specific symptom questionnaire for gastroesophageal reflux disease. Dis. Esophagus 13, 265–270 (2000).
   PubMed Web of Science ®Google Scholar
• Tew S, Jamieson GG, Pilowksy I eta]. The illness behavior of patients with gastroesophageal reflux disease with and without endoscopic esophagitis. Dis. Esophagus 10, 9–15 (1997).
   PubMedGoogle Scholar
• Eloubeidi MA, Provenzale D. Health-related quality of life and severity of symptoms in patients with Barretes esophagus and gastroesophageal reflux disease patients without Barrettes esophagus. Am.j Gastmenterol 95, 1881–1887 (2000). Shows that there is no relationship between symptom severity and health-related quality of life in Barretfs and reflux disease.
   Google Scholar
• Lauritzen K, Junghard 0, Eklund S, Wildund I. The effect of esomeprazole 40 mg on healing, reflux symptoms and quality of life in patients with reflux esophagitis. Gastroenterology122, A-200 (2002).
   Google Scholar
• Kulig M, Leodolter AL, Schulte E et al Quality of life in patients with gastroesophageal reflux disease. Qual Life Res. 11, 649, A111 (2002).
   Google Scholar
• Tougas G, Hwang P, Paterson WG et al Dyspeptic symptoms in the general Canadian population; prevalence and impact on quality of life. Gastroenterology 114, A312 (1998).
   Google Scholar
• Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am. Gastmenterol 95, 67–71 (2000).
   Google Scholar
• Talley NJ, Weaver AL, Zinsmeister AR. Impact of functional dyspepsia on quality of life. Dig. Dis. Sci 40, 584–589 (1995).
   Google Scholar
• Wildund I. Quality of life in arthritis patients using nonsteroidal anti-inflammatory drugs. Can. .1. Gastroenterol 13, 129–133 (1999).
   Google Scholar
• Nortvedt MW, Ruse T, Myhr KM eta]. Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology53, 1098–1103 (1999).
   PubMed Web of Science ®Google Scholar
• Talley NJ, Weaver AL, Zinsmeister AR. Impact of functional dyspepsia on quality of life. Dig. Dis. Sci 40, 584–589 (1995).
   Google Scholar
• Vallot T, Bruley des Varannes S, Grimaud JC etal Epidemiology of gastro-esophageal-reflux in general practice. Predictive factors for healthcare utilization in the course of a year. Gastroenterol Clin. Biol. 23, 1139–1144 (1999).
   PubMedGoogle Scholar
• Crawley JA, Maclin Smith C. How satisfied are chronic heartburn sufferers with their prescription medications? Results from the patient unmet needs survey. J. Clin. Outcomes Manag. 11, 29–34 (2000).
   Google Scholar
• Coyne K, Schmier J, Halling K eta]. Patient and physician ratings of treatment satisfaction for GERD and dyspepsia: are they the same? The Drug Information Association Eighth Annual Symposium of Contributed Papers- on Quality of Life Evaluation, Hilton Head, SC, USA (2001).
   Google Scholar
• Boath EH, Blenkinsopp A. The rise and rise of proton pump inhibitor drugs: patients perspectives. Soc. Sci. Med. 45, 1571–1579 (1997).
   PubMed Web of Science ®Google Scholar
• Kleinman L, McIntosh E, Ryan M etal Willingness to pay for complete symptom relief of gastroesophageal reflux disease. Anh. Intern Med. 162, 1361–1366 (2002).
   Google Scholar
• Jacksson JL, Kroenke K. The effect of unmet expectations among adults presenting with physical symptoms. Ann. Intern. Med. 134, 889–897 (2001).
   PubMedGoogle Scholar
• Bernklev T, Hatlebakk JG, Madsen P etal Omeprazole but not cisapricde, improves quality of life in patients with heartburn treated in primary care. Digestion 59 (Suppl. 3), 1-757(A4155) (1998).
   Google Scholar
• Lind T, Havelund T, Carlsson R etal Heartburn without esophagitis: Efficacy of omeprazole therapy and features of therapeutic response. Scand. Gastroenterol 32, 974–979 (1997).
   PubMed Web of Science ®Google Scholar
• Bardhan KD, Muller-Lissner S, Bigard MA etal Symptomatic gastroesophageal reflux disease (GERD): intermittent treatment (IT) with omeprazole (OM) and ranitidine (RAN) as a strategy for management. Gastroenterology112 (Suppl.), A65 (1997).
   Google Scholar
• Armstrong D, Barkun AN, Chiba N etal Start high, a better acid suppression strategy for heartburn predominant uninvestigated dyspepsia in primary care — the CADET HR study. Gastroentemlogy122, A–472 (2002).
   Google Scholar
• Lind T, Rydberg L, Kyleback A etal Esomeprazole provides improved acid control vs omeprazole in patients with symptoms of gastro-oesophageal reflux disease. Aliment. Pharmacol Ther. 14, 861–867 (2000).
   PubMed Web of Science ®Google Scholar
• Rohss K, Hasselgren G, Hedenstrom H. Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease. Dig. Dis. Sci. 47, 954–958 (2002).
   Google Scholar
• Green JRB, Venables TL, Bate CM etal Omeprazole produces a greater improvement in quality of life than placebo, antacid-alginate, cimetidine or cisapride in patients with gastroesophageal reflux disease. Br. Med. Econ. 11, 121–131 (1997).
   Google Scholar
• Hatlebakk JG, Hyggen A, Madsen PH etal on behalf of the Norwegian Heartburn Study Group. Heartburn treatment in primary care: randomised, double-blind study for 8 weeks. BE Med. 319, 550–553 (1999).
   Google Scholar
• Galmiche JP, Barthelemy P, Hamelin B. Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment. Pharmacol Ther. 11, 765–773 (1997).
   Google Scholar
• Goves J, Oldring JK, Kerr D et al First line treatment with omeprazole provides an effective and superior alternative strategy in the management of dyspepsia compared to antacid alginate liquid: a multicentre study in general practice. Aliment. Pharmacol Ther. 12, 147–157 (1998).
   PubMedGoogle Scholar
• Talley NJ, Meineche-Schmidt V, Pare P etal Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment. Pharmacol Ther. 12, 1055–1065 (1998).
   PubMed Web of Science ®Google Scholar
• Peura DA, Kovacs 0, Metz D etal Low-dose lansoprazole: effective for nonulcer dyspepsia (NUM Gastroenterology118, A-470 (2000).
   Google Scholar
• Johanson JF, Siddique R, Damian° AM etal Rabeprazole improves health-related quality of life in patients with erosive gastroesophageal reflux disease. Dig. Dis. Sc]. 47, 2574–2578 (2002).
   PubMedGoogle Scholar
• Mathias SD, Castell DO, Elkin EP etal Health-related quality of life of patients with acute erosive reflux esophagitis. Dig. Dis. Sc]. 41, 2123–2129 (1996).
   PubMedGoogle Scholar
• Mathias SD, Colwell HH, Miller DP etal Health related quality of life days incrementally gained in symptomatic nonerosive GERD patients treated with lanzoprazole or ranitidine. Dig. Dis. Sc]. 46, 2416–2423 (2001).
   PubMed Web of Science ®Google Scholar
• Carlsson R, Dent J, Watts R etal and the International GORD Study Group. Gastroesophageal reflux disease (GORD) in primary care: an international study of different treatment strategies with omeprazole. Eur. j Gastroenterol Hepatol 10, 119–124 (1998).
   Google Scholar
• Vakil N, Ryden-Bergsten T, Bergenheim K. Systematic review: patient-centred end points in economic evaluations of gastroesophageal reflux disease. Aliment. Pharmacol Ther. 16, 1469–1480 (2002).
   PubMedGoogle Scholar
• ••Emphasizes the patient and societalperspective.
   Google Scholar
• Sandler R, Everhart JE, Donowitz M eta]. The burden of selected digestive diseases in the United States. Gastroentemlogy122, 1500–1511 (2002).
   Google Scholar
• Inadomi JM, Jamal R, Murata GH etal Stepdown management of gastroesophageal reflux disease. Gastmenterology121, 1095–1100 (2001).
   PubMed Web of Science ®Google Scholar
• •Identifies the differential impact of different treatment strategies.
   Google Scholar
• van der Molen T, Postma DS, Schreurs AJ etal Discriminative aspects of two generic and two asthma-specific instruments: relation with symptoms, bronchodilator use and lung function in patients with mild asthma. Qual Life Res. 6, 353–361 (1997).
   PubMed Web of Science ®Google Scholar
• Hann DM, Jacobsen PB, Martin SC etal Quality of life following bone marrow transplantation for breast cancer: a comparative study. Bone Marrow 7iansplant. 19, 257–264 (1997).
   Google Scholar